Under the terms of the collaborative agreement, VaxyGen and Georgia State University will work in the commercial development of the resident know-how and technology.
VaxyGen provides custom contract services in support of biological process optimization, scale-up and the development of manufacturing processes relative to biopharmaceutical and vaccine products.
The Georgia State University Research Foundation supports the research, technology commercialization and economic development activities of GSU.